Evaluation of the chromogenic anti-factor IIa assay to assess dabigatran exposure in geriatric patients with atrial fibrillation in an outpatient setting
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Luyendyk, James P.
Aleksunes, Lauren M.
Funding for this research was provided by:
National Institute of Environmental Health Sciences (ES005022)